Detalhe da pesquisa
1.
A Potent Recombinant Polyclonal Antibody Therapeutic for Protection Against New Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern.
J Infect Dis
; 228(5): 555-563, 2023 08 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37062677